1. Home
  2. TRDA vs NRIM Comparison

TRDA vs NRIM Comparison

Compare TRDA & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • NRIM
  • Stock Information
  • Founded
  • TRDA 2016
  • NRIM 1990
  • Country
  • TRDA United States
  • NRIM United States
  • Employees
  • TRDA N/A
  • NRIM N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • NRIM Savings Institutions
  • Sector
  • TRDA Health Care
  • NRIM Finance
  • Exchange
  • TRDA Nasdaq
  • NRIM Nasdaq
  • Market Cap
  • TRDA 502.9M
  • NRIM 463.5M
  • IPO Year
  • TRDA 2021
  • NRIM N/A
  • Fundamental
  • Price
  • TRDA $9.56
  • NRIM $73.25
  • Analyst Decision
  • TRDA Strong Buy
  • NRIM
  • Analyst Count
  • TRDA 3
  • NRIM 0
  • Target Price
  • TRDA $25.67
  • NRIM N/A
  • AVG Volume (30 Days)
  • TRDA 108.5K
  • NRIM 28.9K
  • Earning Date
  • TRDA 05-06-2025
  • NRIM 04-23-2025
  • Dividend Yield
  • TRDA N/A
  • NRIM 3.39%
  • EPS Growth
  • TRDA N/A
  • NRIM 47.44
  • EPS
  • TRDA 1.68
  • NRIM 6.62
  • Revenue
  • TRDA $210,782,000.00
  • NRIM $151,931,000.00
  • Revenue This Year
  • TRDA N/A
  • NRIM $4.26
  • Revenue Next Year
  • TRDA N/A
  • NRIM $6.21
  • P/E Ratio
  • TRDA $5.76
  • NRIM $11.08
  • Revenue Growth
  • TRDA 63.38
  • NRIM 20.78
  • 52 Week Low
  • TRDA $9.51
  • NRIM $43.92
  • 52 Week High
  • TRDA $21.79
  • NRIM $91.72
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 30.19
  • NRIM 39.25
  • Support Level
  • TRDA $9.75
  • NRIM $72.53
  • Resistance Level
  • TRDA $10.87
  • NRIM $76.60
  • Average True Range (ATR)
  • TRDA 0.53
  • NRIM 1.82
  • MACD
  • TRDA -0.00
  • NRIM 0.33
  • Stochastic Oscillator
  • TRDA 2.70
  • NRIM 42.44

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.

Share on Social Networks: